Taiwan draws foreign biotech IPOs


Vibrant scene: Taiwan is home to the largest number of listed biotechnology companies in Asia with the sector expanding due to a well-educated workforce, historic appetite for high-tech industries and government support. – AFP

Singapore firm working on experimental cancer drugs plans listing by end-May

HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , IPO , cancer , drugs , Taiwan

Next In Business News

Data centres underpin earnings for power companies�
MyBeST charges up for execution
Earnings season, inflation data pose test for resilient US stocks
Singapore’s Nasdaq link draws interest
If I were Ganoderma on oil palm trees
Little impact from delays in certification for doctors
KSL’s quiet transformation
MiniMax shares double in IPO debut
The Week Ahead
ART system set to transform Sarawak transport�

Others Also Read